Baiji China: the tentative list is a normal step and will not affect the listing of the company on NASDAQ
As for the five companies listed in the provisional list of the US foreign company Accountability Act (hfcaa), "this provisional identification list is not a new policy, but a normal step taken by the SEC to implement hfcaa and relevant implementation rules." Baiji Shenzhou insiders told reporters that at present, this matter does not affect Baiji Shenzhou's listing on NASDAQ.
This text is a result of machine translation.
Related companies：
Briefing Jun 10, 2022 09:48 PM
Singaporean Prime Minister Lee Hsien Loong meets with weifenghe
In-depth
Briefing Jun 10, 2022 07:17 PM
Baiji Shenzhou PD-1 monoclonal antibody baizean ® The ninth indication was obtained and the first-line treatment for nasopharyngeal carcinoma was approved
Briefing Apr 28, 2022 09:59 AM
A new breakthrough in the first-line treatment of advanced esophageal cancer: PD-1 monoclonal antibody baizean ® Global phase 3 clinical trials reached the primary end point
Apr 26, 2022 12:26 PM
Apr 21, 2022 07:07 PM
Jun 29, 2021 11:48 PM
May 03, 2021 09:18 AM
Briefing Feb 25, 2022 08:48 PM
Ministry of agriculture and rural areas: implement the ten-year fishing ban on the Yangtze River in 2022 and promote the conservation of aquatic biological resources
Briefing Feb 15, 2022 06:19 AM
· Automotive
Hillhouse Q4 position: increased holdings of ideal automobile and Xiaopeng automobile sea, and ideal automobile rushed into the top ten
Briefing Jan 31, 2022 10:29 AM
· Healthcare
Hong Kong Pharmaceutical stocks generally rose, with Cinda biology up nearly 6%
Briefing Jan 05, 2022 11:24 AM
· Healthcare
54% off! Pamipali, the first PARP inhibitor approved for the treatment of platinum sensitive and platinum resistant recurrent ovarian cancer, was included in Medicare
See more
Read next
Insight
In-depth
Consumer Staples · Analysis
Chinese Cuisine Brand YGF Malatang Ventures into Brazil
Yesterday 02:21 PM